Send feedback

SSTR2 p.Ala4Val

c.11C>T · VCV3449872

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.134 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00401%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.134likely benign
REVEL0.082moderately benign-leaning
SaProtLLR -6.93tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.8
Regional constrainto/e 0.99unconstrained · MANE · 186 bp · p 0.96 · regional, not allelic
Overall
CADD0.237PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00401% African / African-American · 3/74,888 alleles
Filtering AF 0.00106% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000495%
Overall 0.000931% 15/1,611,512 alleles · very rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00401% 24,963
South Asian 0.00221% 45,347
Admixed American 0.00167% 59,772
Remaining individualsnot grpmax-eligible 0.0016% 62,366
European (non-Finnish) 0.000678% 147,386

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SSTR2
Protein
p.Ala4Val
Coding
c.11C>T
MANE Select
NM_001050
Type
single nucleotide variant
Location
chr17:73169330 (GRCh38)
Gene constraint
LOEUF 0.756 · pLI 0.14 (gnomAD)
Structure
AlphaFold pLDDT 81.75 · 17 PDB
Full SSTR2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sstr2-p-ala4val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown